Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated. Copyright 2024 NPR The biggest portion of Boise ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...